fifa fish sarl
In the wee hours Sunday at the United Nations climate talks, countries from around the world reached an agreement on how rich countries can cough up the funds to support poor countries in the face of climate change. It's a far-from-perfect arrangement, with many parties still unsatisfied but some hopeful that the deal will be a step in the right direction. 24/7 San Diego news stream: Watch NBC 7 free wherever you are World Resources Institute president and CEO Ani Dasgupta called it “an important down payment toward a safer, more equitable future,” but added that the poorest and most vulnerable nations are “rightfully disappointed that wealthier countries didn’t put more money on the table when billions of people’s lives are at stake.” The summit was supposed to end on Friday evening but negotiations spiraled on through early Sunday. With countries on opposite ends of a massive chasm, tensions ran high as delegations tried to close the gap in expectations. New study details climate change's impact on the strength of hurricanes Biden to become the first sitting US president to visit the Amazon rainforest World's most polluting cities revealed at COP29: NYC, Houston among top emitters Here's how they got there: What was the finance deal agreed at climate talks? Rich countries have agreed to pool together at least $300 billion a year by 2035. It’s not near the full amount of $1.3 trillion that developing countries were asking for, and that experts said was needed. But some delegations said this deal is headed in the right direction, with hopes that more money flows in the future. The text included a call for all parties to work together using “all public and private sources” to get closer to the $1.3 trillion per year goal by 2035. That means also pushing for international mega-banks, funded by taxpayer dollars, to help foot the bill. And it means, hopefully, that companies and private investors will follow suit on channeling cash toward climate action. The agreement is also a critical step toward helping countries on the receiving end create more ambitious targets to limit or cut emissions of heat-trapping gases that are due early next year. It’s part of the plan to keep cutting pollution with new targets every five years, which the world agreed to at the U.N. talks in Paris in 2015. The Paris agreement set the system of regular ratcheting up climate fighting ambition as away to keep warming under 1.5 degrees Celsius (2.7 degrees Fahrenheit) above pre-industrial levels. The world is already at 1.3 degrees Celsius (2.3 degrees Fahrenheit) and carbon emissions keep rising. What will the money be spent on? The deal decided in Baku replaces a previous agreement from 15 years ago that charged rich nations $100 billion a year to help the developing world with climate finance. The new number has similar aims: it will go toward the developing world's long laundry list of to-dos to prepare for a warming world and keep it from getting hotter. That includes paying for the transition to clean energy and away from fossil fuels. Countries need funds to build up the infrastructure needed to deploy technologies like wind and solar power on a large scale. Communities hard-hit by extreme weather also want money to adapt and prepare for events like floods, typhoons and fires. Funds could go toward improving farming practices to make them more resilient to weather extremes, to building houses differently with storms in mind, to helping people move from the hardest-hit areas and to help leaders improve emergency plans and aid in the wake of disasters. The Philippines, for example, has been hammered by six major storms in less than a month, bringing to millions of people howling wind, massive storm surges and catastrophic damage to residences, infrastructure and farmland. “Family farmers need to be financed," said Esther Penunia of the Asian Farmers Association. She described how many have already had to deal with millions of dollars of storm damage, some of which includes trees that won't again bear fruit for months or years, or animals that die, wiping out a main source of income. “If you think of a rice farmer who depends on his or her one hectare farm, rice land, ducks, chickens, vegetables, and it was inundated, there was nothing to harvest,” she said. Why was it so hard to get a deal? Election results around the world that herald a change in climate leadership, a few key players with motive to stall the talks and a disorganized host country all led to a final crunch that left few happy with a flawed compromise. The ending of COP29 is "reflective of the harder geopolitical terrain the world finds itself in,” said Li Shuo of the Asia Society. He cited Trump's recent victory in the US — with his promises to pull the country out of the Paris Agreement — as one reason why the relationship between China and the EU will be more consequential for global climate politics moving forward. Developing nations also faced some difficulties agreeing in the final hours, with one Latin American delegation member saying that their group didn't feel properly consulted when small island states had last-minute meetings to try to break through to a deal. Negotiators from across the developing world took different tacks on the deal until they finally agreed to compromise. Meanwhile, activists ramped up the pressure: many urged negotiators to stay strong and asserted that no deal would be better than a bad deal. But ultimately the desire for a deal won out. Some also pointed to the host country as a reason for the struggle. Mohamed Adow, director of climate and energy think tank Power Shift Africa, said Friday that “this COP presidency is one of the worst in recent memory,” calling it “one of the most poorly led and chaotic COP meetings ever.” The presidency said in a statement, “Every hour of the day, we have pulled people together. Every inch of the way, we have pushed for the highest common denominator. We have faced geopolitical headwinds and made every effort to be an honest broker for all sides.” Shuo retains hope that the opportunities offered by a green economy “make inaction self-defeating” for countries around the world, regardless of their stance on the decision. But it remains to be seen whether the UN talks can deliver more ambition next year. In the meantime, “this COP process needs to recover from Baku,” Shuo said. ___ Associated Press reporters Seth Borenstein and Sibi Arasu contributed to this report. ___ The Associated Press’ climate and environmental coverage receives financial support from multiple private foundations. AP is solely responsible for all content. Find AP’s standards for working with philanthropies, a list of supporters and funded coverage areas at AP.org.
VP pick and roll. Former Kamala Harris campaign surrogate and “Shark Tank” mogul Mark Cuban believes he can win the presidency by choosing an NBA legend as his running mate, the NY Post reports. Average of 9 LIVE Regular Season games per week plus the best of the NBA Playoffs, including every game of the NBA Conference Finals & NBA Finals LIVE on ESPN, available via Kayo New to Kayo? Get your first month for just $1. Limited time offer. During an appearance on “The Steam Room” podcast, hosted by NBA TNT television personalities Ernie Johnson and Charles Barkley, Cuban answered whether his recent turn as a political pundit would result in seeking elected office. Cuban first said “hell no,” about running for higher office, but said one thing could possibly change his mind. “Would your feeling on a run for office change if it were, say, a ticket of you and the Chuckster,” legendary basketball announcer Ernie Johnson asked, referring to his co-host as the potential running mate. “Yes, absolutely,” Cuban replied with relish. “We’d win running away. No question about it.” “We’d win,” Barkley said in matter-of-fact agreement. “We’d definitely win. Yes absolutely, running away.” MORE: Ivanka reveals ‘hurtful toll’ behind Trump snub Cuban heaped praise on Barkley, all but calling him a role model for civility and personability. “Charles can talk to anybody and put himself in any circumstance and get along with everybody, and I think that’s what we need,” Cuban said. Moments before, the Round Mound of Rebound himself asked Cuban whether he “seriously considered” seeking an elected office. “I did a little bit,” Cuban said with a wince. “I even talked to a pollster. But then I talked to my family and we took a family vote and they said, “hell no.” Cuban further elaborated that he believes today’s politics is “meaner” and that the “hate on social media” serves as a legitimate deterrent to his civic impulses. “If your kids live on social media, why would I put them through that?” Cuban asked rhetorically. Cuban, who was an active surrogate for the Harris campaign, said he was disappointed with Trump’s election victory in November —- but he is more focused on the future than the past. MORE: High roller Trump kids’ multimillion dollar digs “What’s your first, initial reaction to the election going forward,” Barkley asked the minority owner of the Dallas Mavericks. “It’s like losing the last game of the season. You know? It’s a horrible feeling; walking off the court is awful. But, you know, you’ve got to look forward to next season,” said Cuban. “You can’t dwell on it, you’ve got to think what you can do going forward, and I care about this country, I love this country, and that’s important to me. It’s not about “I hate this person” or “I hate that person.” No. It’s about what can we do going forward,” he stated. The billionaire turned political pundit made news throughout the election cycle, oftentimes due to high-profile flubs. Cuban faced backlash after claiming Donald Trump doesn’t surround himself with “strong, intelligent women.” “They’re intimidating to him. He doesn’t like to be challenged by them, and, you know, Nikki Haley will call him on his nonsense with reproductive rights and how he sees and treats and talks about women. I mean, he just can’t have her around. It wouldn’t work,” Cuban said on “The View” at the time. He later apologised for the comments that were seen as dismissive and disrespectful to conservative women. The billionaire was also roundly mocked in online conservative circles during the campaign — with many suggesting that his new black-rimmed glasses bring out a resemblance to liberal MSNBC talk show host Rachel Maddow. This article originally appeared on the NY Post and was reproduced with permission.New Era in Gaming! Growth Stocks to Watch in Tech-Fueled FutureNetflix 'totally ready' for XMas NFL games, WWE
Sinha paid tribute to former Prime Minister Atal Bihari Vajpayee and Mahamana Pandit Madan Mohan Malaviya on the occasion of their birth anniversary. Addressing a commemorative event at Pt. Madan Mohan Malaviya Inter College in Ghazipur, the Lieutenant Governor said, Mahamana Pandit Madan Mohan Malaviya and Atal Bihari Vajpayee represent the conscience of Bharat. He said the vision of the two giant leaders paved the way for socio-economic transformation of the nation. “Mahamana's relentless pursuit of public welfare and nation building had shaped the idea of self-reliant, modern and united India. The vision of Mahamana had opened up new frontiers in education, technology and industrial development of the country,” the Lieutenant Governor said. Paying homage to Atal Bihari Vajpayee, the Lieutenant Governor spoke on the lifelong campaigns of the former Prime Minister dedicated to nation building and public welfare. “Nation should be supreme for an individual. To ensure this Atal Ji gave us the principles of 'Indianization' and 'Nation-First'. Every section of society should work together to make the country self-reliant with undivided loyalty,” he said. The Lieutenant Governor called upon the people, especially the youth to rededicate themselves to the ideals of Mahamana and Shri Atal Bihari Vajpayee and strive to build a progressive society and work unitedly to realise the vision of Viksit Bharat. “We do not have to live in the past but we must take inspiration from history to build a brighter future,” he said. He highlighted that the Youth have a very important role to play in taking public services to the grassroots levels. To achieve this, we need to start shaping a new framework for Jan-Bhagidari and use new technologies for transparency and accountability at all levels, he added. “Unity is our greatest strength. Young generation must unite the society with determination. I want to see every hand working like a skilled sculptor to create a beautiful, victorious and prosperous India. I want to see a sense of responsibility, steadfastness towards duties and steely determination in every youth towards nation-building,” the LG said. The Lieutenant Governor emphasised that our cultural ideals and values should be paramount for the new political and economic system. “Today is the opportunity for us to build a brighter tomorrow for the country and to ensure that societal attitudes are changed towards responsibilities. Whole of Government Approach should be adopted to achieve socio-economic goals,” the LG observed. Follow this link to join our WhatsApp group : Join Now Be Part of Quality Journalism Quality journalism takes a lot of time, money and hard work to produce and despite all the hardships we still do it. Our reporters and editors are working overtime in Kashmir and beyond to cover what you care about, break big stories, and expose injustices that can change lives. Today more people are reading Kashmir Observer than ever, but only a handful are paying while advertising revenues are falling fast. CLICK FOR DETAILS MENAFN25122024000215011059ID1109030091 Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.‘American Idol’ Alum Caleb Kennedy Pleads Guilty, Gets 8 Years in Prison After Fatal DUI CrashMeta to build $10 billion AI data center in Louisiana as Elon Musk expands his Tennessee AI facility
Illinois St. 84, UAB 83
Black plastic kitchen utensil risks were overstated. But you should still toss them, group saysWASHINGTON D.C., DC — The Dallas Mavericks take on the Washington Wizards at 6 p.m. CT Thursday on KFAA! Not sure how to watch? Here's a breakdown on how to tune in – and guarantee you get the clearest signal possible of the broadcast. The Dallas Mavericks (14-8) have won five in a row and are looking to ride that hot streak into Thursday night when they take on the Washington Wizards (2-17). The Mavs earned the wildcard spot in the NBA Cup Tuesday night against the Grizzlies and now will have work to carry that momentum over in this regular season matchup against a struggling, injured Wizards team. This will be the first of a three-away-game stint for the Mavs. If they lose in Tuesday's Cup Night Quarterfinals matchup against OKC, the Mavs won't return home for a game until Dec. 19 against the Clippers. Dallas Mavericks injury report Kessler Edwards: Out (G-League Two-way) Dante Exum: Out (right wrist surgery) Jazian Gortman: Out (G-League Two-way) Naji Marshall: Out (illness) Brandon Williams: Out (G-League Two-way) Washington Wizards injury report Patrick Baldwin Jr.: Out (right ankle soreness) Saddiq Bey: Out (left knee ACL surgery) Malcolm Brogdon: Available (right knee soreness) Kyshawn George: Out (left ankle sprain) Corey Kispert: Out (left ankle sprain Kyle Kuzma: Out (left rib sprain) Tristan Vukcevic: Out (left knee contusion) What's next Following tonight's matchup with the Wizards, the Mavericks will travel up to Toronto to take on the Raptors. Saturday, Dec. 7: at Toronto Raptors on KFAA at 6:30 p.m. CT Thursday, Dec. 19: at LA Clippers on WFAA/KFAA at 7:30 p.m. CT Tuesday, Dec. 10: at OKC Thunder on TNT at 8:30 p.m. CT *Cup Night Quarterfinals
'This wasn't my year' - Christian McCaffrey makes 2025 promise after 49ers star's latest injuryPrenatal and Newborn Genetic Testing Market Size: Strong Growth Ahead (2024-2032) 12-25-2024 03:37 PM CET | Health & Medicine Press release from: Cognate Insights Prenatal and Newborn Genetic Testing Market Latest Market Overview The global prenatal and newborn genetic testing market is anticipated to reach USD 11.5 billion in 2024, with projections to expand to USD 23.8 billion by 2032, reflecting a compound annual growth rate (CAGR) of 9.7%. The market's robust growth is primarily fueled by rising awareness of genetic conditions, advancements in diagnostic technologies, and increased demand for early disease detection. Prenatal and newborn genetic testing aids in identifying potential genetic abnormalities, providing critical insights for timely interventions and enhanced patient care outcomes, making these testing solutions essential within modern healthcare systems. The Prenatal and Newborn Genetic Testing Market has experienced steady growth in recent years and is expected to continue expanding at a strong pace from 2024 to 2032. This analysis offers a comprehensive overview, providing valuable insights into key trends and developments within the Prenatal and Newborn Genetic Testing industry. These findings equip business leaders with the necessary knowledge to devise more effective strategies and enhance profitability. Furthermore, the report serves as a useful resource for new and emerging businesses, helping them make informed decisions as they navigate the market and seek growth opportunities. Major Players of Prenatal and Newborn Genetic Testing Market are: Illumina, Inc. (San Diego, USA) - Revenue: USD 5.5 billion Thermo Fisher Scientific, Inc. (Waltham, USA) - Revenue: USD 39 billion F. Hoffmann-La Roche AG (Basel, Switzerland) - Revenue: USD 67 billion Agilent Technologies (Santa Clara, USA) - Revenue: USD 7.1 billion PerkinElmer Inc. (Waltham, USA) - Revenue: USD 3.7 billion Get Latest PDF Sample Report @ https://www.cognateinsights.com/request-sample/prenatal-and-newborn-genetic-testing-market-research Our Report covers global as well as regional markets and provides an in-depth analysis of the overall growth prospects of the market. Global market trend analysis including historical data, estimates to 2024, and compound annual growth rate (CAGR) forecast to 2032 is given based on qualitative and quantitative analysis of the market segments involving economic and non-economic factors. Furthermore, it reveals the comprehensive competitive landscape of the global market, the current and future market prospects of the industry, and the growth opportunities and drivers as well as challenges and constraints in emerging and emerging markets. Global Prenatal and Newborn Genetic Testing Market Landscape and Future Pathways: North America: United States Canada Europe: Germany France U.K. Italy Russia Asia-Pacific: China Japan South Korea India Australia China Taiwan Indonesia Thailand Malaysia Latin America: Mexico Brazil Argentina Korea Colombia Middle East & Africa: Turkey Saudi Arabia UAE Korea Speak to Our Analyst for A Discussion on The Above Findings, And Ask for A Discount on The Report @ https://www.cognateinsights.com/check-discount/prenatal-and-newborn-genetic-testing-market-research Key drivers and challenges influencing the Prenatal and Newborn Genetic Testing market: Regional Analysis: The report involves examining the Prenatal and Newborn Genetic Testing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets. Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Prenatal and Newborn Genetic Testing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends. Company Analysis: Report covers individual Prenatal and Newborn Genetic Testing manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies. Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Prenatal and Newborn Genetic Testing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application. Technology Analysis: Report covers specific technologies relevant to Prenatal and Newborn Genetic Testing. It assesses the current state, advancements, and potential future developments in Prenatal and Newborn Genetic Testing areas. Reason to Buy this Report: -Analysis of the impact of technological advancements on the market and the emerging trends shaping the industry in the coming years. -Examination of the regulatory and policy changes affecting the market and the implications of these changes for market participants. -Overview of the competitive landscape in the Prenatal and Newborn Genetic Testing market, including profiles of the key players, their market share, and strategies for growth. -Identification of the major challenges facing the market, such as supply chain disruptions, environmental concerns, and changing consumer preferences, and analysis of how these challenges will affect market growth. -Evaluation of the potential of new products and applications in the market, and analysis of the investment opportunities for market participants. For In-Depth Competitive Analysis - Purchase this Report now at @ https://www.cognateinsights.com/purchase-report/prenatal-and-newborn-genetic-testing-market-research Contact Us: Cognate Insights Web: www.cognateinsights.com Email: info@cognateinsights.com Phone: +91 8424946476 About Us: We are leaders in market analytics, business research, and consulting services for Fortune 500 companies, start-ups, financial & government institutions. Since we understand the criticality of data and insights, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. To be at our client's disposal whenever they need help on market research and consulting services. We also aim to be their business partners when it comes to making critical business decisions around new market entry, M&A, competitive Intelligence and strategy. This release was published on openPR.ANDOVER, Mass. , Dec. 2, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced the appointment of Mr. Gerardo Hernandez as the Company's Chief Financial Officer, effective December 2, 2024 . In this role, Mr. Hernandez joins the TransMedics executive leadership team, succeeding Mr. Stephen Gordon . To enable a smooth transition, Mr. Gordon will remain a non-executive employee of the Company until March 31, 2025 , before serving as a non-employee senior advisor to the Company focusing on national transplant stakeholder engagement until March 31, 2026 . TransMedics also updated its 2024 financial outlook. Dr. Waleed Hassanein , Mr. Gerardo Hernandez and Mr. Stephen Gordon will attend the upcoming Piper Sandler Conference on December 3, 2024 , the TransMedics Investor & Analyst Day on December 10, 2024 , as well as the J.P. Morgan Healthcare Conference in January 2025 . Mr. Hernandez is an accomplished finance leader with over 25 years of experience across the healthcare and consumer packaged goods (CPG) sectors. He most recently served as Vice President Finance, Head of Corporate Financial Planning and Analysis at Alnylam Pharmaceuticals, a biopharmaceutical company focused on RNAi therapeutics. In this role, Mr. Hernandez led a global team as the company scaled rapidly. Prior to his role at Alnylam, Mr. Hernandez spent nearly a decade at Shire, where he rose through the organization, eventually leading corporate FP&A. During his tenure, Shire was acquired by Takeda in a $62 billion transaction, after which he was instrumental in the integration effort. Mr. Hernandez began his career at Unilever where he held several finance roles of increasing responsibility before joining Shire in 2010. Mr. Hernandez holds a Bachelor of Science degree in Finance from the University of Wisconsin , La Crosse and an MBA in Strategy and Economics from Fundação Getulio Vargas , Sao Paulo, Brazil . "Stephen has been an exceptional partner to me as a member of the TransMedics leadership team for nearly a decade. During his tenure we transitioned the Company from a clinical stage organization to a high growth, publicly traded commercial business," said Waleed Hassanein , M.D., President and Chief Executive Officer. "On behalf of the entire management team and the Board, I want to thank Stephen for his countless contributions to our business that will have lasting benefits for the Company. I am grateful for Stephen's dedication and efforts to advance our corporate strategy while delivering considerable shareholder value, and I look forward to his continued partnership to affect a smooth transition as we start our next chapter at TransMedics." "I am delighted to welcome Gerardo to the TransMedics leadership team as our new Chief Financial Officer," added Dr. Hassanein. "His proven record over two decades of leadership across FP&A functions within high-growth, complex global organizations makes him an ideal addition to our team. I am looking forward to partnering with Gerardo as we continue to deliver significant long-term corporate growth and shareholder value." "I am thrilled to join TransMedics as Chief Financial Officer," said Mr. Hernandez. "I look forward to working with the entire leadership team to expand access to the Company's unparalleled products and services in the organ transplant field while enhancing operational efficiency and delivering lasting value to both our shareholders and the patients we serve." Dr. Hassanein concluded, "As we enter the final weeks of the fourth quarter, we are also updating our financial outlook for the full year 2024. Our updated guidance reflects our continued expectation for considerable year-over-year revenue growth. We look forward to providing additional context at our upcoming Investor & Analyst Day." 2024 Financial Outlook TransMedics now expects revenue for the full year 2024 to be in the range of $428 million to $432 million, which represents 77% to 79% growth compared to the Company's prior year revenue. Piper Sandler 36th Annual Healthcare Conference Members of the TransMedics management team will participate in a fireside chat at the upcoming Piper Sandler 36th Annual Healthcare Conference at the Lotte New York Palace. The fireside chat will take place on Tuesday, December 3, 2024 , at 4:00 p.m. Eastern Time . A live and archived webcast of the fireside chat will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com . The Company's standard investor presentation is also available through this link. TransMedics Investor & Analyst Day Details TransMedics will discuss the transition and updated financial outlook, as well as the Company's growth strategy, clinical pipeline, and operations, in greater detail at its Investor & Analyst Day in New York City on Tuesday, December 10, 2024 , at 10:00 a.m. Eastern Time . A live and archived webcast of presentations and Q&A sessions will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com . Please note management will only take questions from the live audience during the question-and-answer session following formal presentations. About TransMedics Group, Inc. TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts , the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure. Forward-Looking Statements This press release contains forward-looking statements with respect to, among other things, a leadership transition and our full-year guidance. For this purpose, all statements other than statements of historical facts are forward-looking statements. The words "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "expect," "should," "could," "target," "predict," "seek" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are subject to a number of risks and uncertainties. Our management cannot predict all risks, nor can we assess the impact of all factors or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in or implied by any forward-looking statements we may make. In light of these risks and uncertainties, the forward-looking events and circumstances discussed in this press release may not occur and actual results could differ materially and adversely from those anticipated in or implied by the forward-looking statements. Some of the key factors that could cause actual results to differ include: our ability to maintain profitability on a sustained basis; our ability to attract, train and retain key personnel; our existing and any future indebtedness, including our ability to comply with affirmative and negative covenants under our credit agreement to which we will remain subject until maturity; the fluctuation of our financial results from quarter to quarter; our need to raise additional funding and our ability to obtain it on favorable terms, or at all; our ability to use net operating losses and research and development credit carryforwards; our dependence on the success of the Organ Care System or OCS; our ability to expand access to the OCS through our National OCS Program or NOP; our ability to scale our manufacturing and sterilization capabilities to meet increasing demand for our products; the rate and degree of market acceptance of the OCS; our ability to educate patients, surgeons, transplant centers and private and public payors on the benefits offered by the OCS; our ability to improve the OCS platform and develop the next generation of the OCS products; our dependence on a limited number of customers for a significant portion of our revenue; our ability to maintain regulatory approvals or clearances for our OCS products in the United States , the European Union, and other select jurisdictions worldwide; our ability to adequately respond to the Food and Drug Administration or FDA, or other competent authorities, follow-up inquiries in a timely manner; the performance of our third-party suppliers and manufacturers; our use of third parties to transport donor organs and medical personnel for our NOP and our ability to maintain and grow our logistics capabilities to support our NOP and reduce dependence on third party transportation, including by means of attracting, training and retaining pilots, and the acquisition, maintenance or replacement of fixed-wing aircraft for our aviation transportation services or other acquisitions, joint ventures or strategic investments; our ability to maintain Federal Aviation Administration or FAA or other regulatory licenses or approvals for our aircraft transportation services; price increases of the components of our products and maintenance, parts and fuel for our aircraft; the timing or results of post-approval studies and any clinical trials for the OCS; our manufacturing, sales, marketing and clinical support capabilities and strategy; attacks against our information technology infrastructure; the economic, political and other risks associated with our foreign operations; our ability to protect, defend, maintain and enforce our intellectual property rights relating to the OCS and avoid allegations that our products infringe, misappropriate or otherwise violate the intellectual property rights of third parties; the pricing of the OCS, as well as the reimbursement coverage for the OCS in the United States and internationally; regulatory developments in the United States, European Union and other jurisdictions; the extent and success of competing products or procedures that are or may become available; our ability to service our 1.50% convertible senior notes, due 2028; the impact of any product recalls or improper use of our products; our estimates regarding revenues, expenses and needs for additional financing; and other factors that may be described in our filings with the Securities and Exchange Commission (the "SEC"). Additional information will be made available in our annual and quarterly reports and other filings that we make with the SEC. The forward-looking statements in this press release speak only as of the date of this press release. Factors or events that could cause our actual results to differ may emerge from time to time, and we are not able to predict all of them. We undertake no obligation to update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by applicable law. Investor Contact: Brian Johnston Laine Morgan 332-895-3222 Investors@transmedics.com View original content to download multimedia: https://www.prnewswire.com/news-releases/transmedics-appoints-gerardo-hernandez-as-chief-financial-officer-and-provides-updated-2024-financial-outlook-302320060.html SOURCE TransMedics Group, Inc.
Northern, rural municipalities get provincial boost
NORTON -- Virginia Gov. Glenn Youngkin on Friday announced the relocation of Wrap Technologies to Southwest Virginia, marking a significant expansion of the company’s commitment to defense and public safety technology. Javascript is required for you to be able to read premium content. Please enable it in your browser settings.
Odisha’s farm economy holds lessons for others
(All times Eastern) Schedule subject to change and/or blackouts Thursday, Dec. 26 COLLEGE FOOTBALL 2 p.m. ESPN — The GameAbove Sports Bowl: Pittsburgh vs. Toledo, Detroit 5:30 p.m. ESPN — The Rate Bowl: Rutgers vs. Kansas St., Phoenix 9 p.m. ESPN — The 68 Ventures Bowl: Arkansas St. vs. Bowling Green, Mobile, Ala. IIHF HOCKEY (MEN’S) Noon NHLN — World Junior Championship Group Stage: Slovakia vs. Sweden, Group B, Toronto 2:30 p.m. NHLN — World Junior Championship Group Stage: U.S. vs. Germany, Group A, Ottawa, Ontario 5 p.m. NHLN — World Junior Championship Group Stage: Czechia vs. Switzerland, Group B, Toronto 7:30 p.m. NHLN — World Junior Championship Group Stage: Finland vs. Canada, Group A, Ottawa, Ontario NBA BASKETBALL 7 p.m. NBATV — Oklahoma City at Indiana 10 p.m. NBATV — Utah at Portland NFL FOOTBALL 8:15 p.m. PRIME VIDEO — Seattle at Chicago SOCCER (MEN’S) 7:30 a.m. USA — Premier League: Everton at Manchester City 10 a.m. USA — Premier League: Aston Villa at Newcastle United 12:30 p.m. USA — Premier League: Manchester United at Wolverhampton 3 p.m. USA — Premier League: Leicester City at Liverpool TENNIS 9 p.m. TENNIS — United Cup: Spain v. Kazakhstan 4 a.m. (Friday) TENNIS — United Cup: China v. Brazil 6 a.m. (Friday) TENNIS — United Cup: China v. Brazil The Associated Press created this story using technology provided by Data Skrive TV listings provided by LiveSportsOnTV .India News | 3 Dead, 9 Injured in Road Accident in Karnataka's Kalaburagi
Scott Bessent’s Husband: Is the Billionaire Secretary of Treasury Nominee Married?Jeremy Clarkson has backpedalled on his previous comments about why he bought his farm, saying he thought it would be a “better PR story if I said I bought it to avoid paying tax”. The TV presenter and journalist defied doctors’ orders by joining thousands of farmers in London on Tuesday to protest against agricultural inheritance tax changes. The 64-year-old, who fronts Prime Video’s Clarkson’s Farm, which documents the trials of farming on his land in Oxfordshire, wrote in a post on the Top Gear website in 2010: “I have bought a farm. There are many sensible reasons for this: Land is a better investment than any bank can offer. The government doesn’t get any of my money when I die. And the price of the food that I grow can only go up.” Clarkson also told the Times in 2021 that avoiding inheritance tax was “the critical thing” in his decision to buy land. Addressing the claim in a new interview with The Times, the former Top Gear presenter said: “I never did admit why I really bought it.” The fan of game bird shooting added: “I wanted to have a shoot – I was very naive. I just thought it would be a better PR story if I said I bought it to avoid paying tax.” Clarkson was among the thousands who took to the streets this week to protest over the changes in the recent Budget to impose inheritance tax on farms worth more than £1m and he addressed the crowds at the march in central London. He told the newspaper he is not happy to be the public face of the movement, saying: “It should be led by farmers.” The presenter said he does not consider himself a farmer because there are “so many basic jobs” which he cannot do, but he feels his role is to “report on farming”. Earlier this month, it was confirmed Clarkson’s Farm, which has attracted huge attention to his Diddly Squat farm shop, had been renewed for a fifth series. Asked whether the issue behind the tax protest is that rural poverty is hidden, Clarkson agreed and said his programme was not helping to address the situation. “One of the problems we have on the show is we’re not showing the poverty either, because obviously on Diddly Squat there isn’t any poverty”, he said. “But trust me, there is absolute poverty. I’m surrounded by farmers. I’m not going out for dinner with James Dyson. “It’s people with 200 acres, 400 acres. Way past Rachel Reeves’s threshold. They are f .” The newspaper columnist also presents Who Wants To Be A Millionaire? on ITV. The Grand Tour, his motoring show with former Top Gear colleagues Richard Hammond and James May, ended in September. Discussing whether he might move into politics, Clarkson said: “I’d be a terrible political leader, hopeless. “I’m a journalist at heart, I prefer throwing rocks at people than having them thrown at me.” However, he said he would be “100% behind any escalation” after the farmers’ march. Clarkson revealed last month he had undergone a heart procedure to have stents fitted after experiencing a “sudden deterioration” in his health which brought on symptoms of being “clammy”, a “tightness” in his chest and “pins and needles” in his left arm. He said in a Sunday Times column that one of his arteries was “completely blocked and the second of three was heading that way” and doctors said he was perhaps “days away” from becoming very ill. Asked if he is thinking about retiring, the Doncaster-born celebrity said: “Probably not. It depends when you die, I always think. “You’d be surprised, us Northerners are made of strong stuff.” Get all the latest news from around the country Scan the QR code on your mobile device for all the latest news from around the country
In-vitro Diagnostics Market to See Rapid Expansion Over the Next Decade 2024-2032 12-25-2024 03:19 PM CET | Health & Medicine Press release from: Cognate Insights In-vitro Diagnostics Market Latest Market Overview : The global in-vitro diagnostics (IVD) market is expected to reach USD 112.5 billion in 2024, growing at a robust compound annual growth rate (CAGR) of 6.4% from 2024 to 2032. In-vitro diagnostics refers to medical tests conducted on samples, such as blood, urine, or tissue, outside the human body to detect conditions, monitor health status, and guide treatment decisions. The market is driven by factors such as increasing demand for early disease detection, advancements in molecular diagnostics, rising healthcare expenditures, and growing patient awareness. With continuous innovations in testing technologies and the rising burden of chronic diseases, the IVD market is poised for sustained growth through the coming decade. The In-vitro Diagnostics Market has experienced steady growth in recent years and is expected to continue expanding at a strong pace from 2024 to 2032. This analysis offers a comprehensive overview, providing valuable insights into key trends and developments within the In-vitro Diagnostics industry. These findings equip business leaders with the necessary knowledge to devise more effective strategies and enhance profitability. Furthermore, the report serves as a useful resource for new and emerging businesses, helping them make informed decisions as they navigate the market and seek growth opportunities. Major Players of In-vitro Diagnostics Market are: Abbott Laboratories (USA) - Revenue: USD 44.0 billion (2023) Siemens Healthineers (Germany) - Revenue: USD 24.4 billion (2023) Roche Diagnostics (Switzerland) - Revenue: USD 19.5 billion (2023) Thermo Fisher Scientific (USA) - Revenue: USD 46.0 billion (2023) Danaher Corporation (USA) - Revenue: USD 30.4 billion (2023) Get Latest PDF Sample Report @ https://www.cognateinsights.com/request-sample/in-vitro-diagnostics-market Our Report covers global as well as regional markets and provides an in-depth analysis of the overall growth prospects of the market. Global market trend analysis including historical data, estimates to 2024, and compound annual growth rate (CAGR) forecast to 2032 is given based on qualitative and quantitative analysis of the market segments involving economic and non-economic factors. Furthermore, it reveals the comprehensive competitive landscape of the global market, the current and future market prospects of the industry, and the growth opportunities and drivers as well as challenges and constraints in emerging and emerging markets. Global In-vitro Diagnostics Market Landscape and Future Pathways: North America: United States Canada Europe: Germany France U.K. Italy Russia Asia-Pacific: China Japan South Korea India Australia China Taiwan Indonesia Thailand Malaysia Latin America: Mexico Brazil Argentina Korea Colombia Middle East & Africa: Turkey Saudi Arabia UAE Korea Speak to Our Analyst for A Discussion on The Above Findings, And Ask for A Discount on The Report @ https://www.cognateinsights.com/check-discount/in-vitro-diagnostics-market Key drivers and challenges influencing the In-vitro Diagnostics market: Regional Analysis: The report involves examining the In-vitro Diagnostics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets. Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the In-vitro Diagnostics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends. Company Analysis: Report covers individual In-vitro Diagnostics manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies. Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards In-vitro Diagnostics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application. Technology Analysis: Report covers specific technologies relevant to In-vitro Diagnostics. It assesses the current state, advancements, and potential future developments in In-vitro Diagnostics areas. Reason to Buy this Report: -Analysis of the impact of technological advancements on the market and the emerging trends shaping the industry in the coming years. -Examination of the regulatory and policy changes affecting the market and the implications of these changes for market participants. -Overview of the competitive landscape in the In-vitro Diagnostics market, including profiles of the key players, their market share, and strategies for growth. -Identification of the major challenges facing the market, such as supply chain disruptions, environmental concerns, and changing consumer preferences, and analysis of how these challenges will affect market growth. -Evaluation of the potential of new products and applications in the market, and analysis of the investment opportunities for market participants. For In-Depth Competitive Analysis - Purchase this Report now at @ https://www.cognateinsights.com/purchase-report/in-vitro-diagnostics-market Contact Us: Cognate Insights Web: www.cognateinsights.com Email: info@cognateinsights.com Phone: +91 8424946476 About Us: We are leaders in market analytics, business research, and consulting services for Fortune 500 companies, start-ups, financial & government institutions. Since we understand the criticality of data and insights, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. To be at our client's disposal whenever they need help on market research and consulting services. We also aim to be their business partners when it comes to making critical business decisions around new market entry, M&A, competitive Intelligence and strategy. This release was published on openPR.
OpenAI chief 'believes' Musk will not abuse government power
Apple shares are on the verge of hitting a record $4 trillion valuation, buoyed by a sharp rise in its price. The company's recent advances in artificial intelligence (AI) and hopes of a recovery in iPhone sales have sparked excitement among investors. Since early November, Apple’s stock has climbed about 16%, adding about $500 billion to its market capitalization. As of its most recent close, the tech giant’s valuation was about $3.85 trillion, surpassing the combined value of the German and Swiss stock exchanges. That growth has helped Apple leapfrog rivals including Nvidia and Microsoft in the race toward the $4 trillion mark. AI Advances Boost Investor Confidence Apple's stock rally is largely attributed to investor optimism about the company's AI advancements, as well as expectations for a supercycle of iPhone upgrades. Despite concerns about slower growth in recent quarters, the company's market performance reflects renewed confidence in its future prospects. Earlier this month, Apple began integrating OpenAI’s ChatGPT into its devices, following its announcement that it would incorporate generative AI into its suite of apps. The move helped boost investor confidence, with many anticipating that AI could play a key role in revitalizing iPhone sales. Apple’s efforts to improve its AI capabilities are seen as a key part of its strategy to unleash the next wave of iPhone evolutions, including the launch of the iPhone 16 series. Analysts are optimistic that the combination of AI advancements and a refreshed product lineup could revive consumer demand for the iPhone, especially in 2025. Although Apple's stock price is recovering strongly, questions remain about the near-term outlook for its iPhone business. The company forecast modest revenue growth for its fiscal first quarter, with expectations for low-to-mid-single-digit increases. That forecast has raised concerns about the momentum of the iPhone 16 series, particularly during the holiday season. However, industry analysts are more optimistic about the future, with many predicting a rebound in iPhone sales by 2025. According to LSEG data, iPhone revenue is expected to recover in the coming years, driven by AI-powered updates and a renewed focus on hardware innovation. Apple’s recent stock rally has pushed its price-to-earnings (P/E) ratio to near a three-year high of 33.5, outpacing rivals such as Microsoft and Nvidia. While that valuation has raised concerns about the stock’s potential overvaluation, overall market sentiment remains positive. Investors are hoping that monetary easing will continue to support stock markets next year, despite recent warnings from the Federal Reserve about slower rate cuts. In addition to its AI efforts, Apple is also working to reduce its reliance on outside suppliers, particularly in the crucial area of mobile chips. The company is preparing to launch its own custom cellular modem chips, which will debut in the iPhone SE, Apple’s entry-level smartphone. The move is a major step toward reducing the company’s reliance on Qualcomm, which has dominated the modem market for years. Apple’s modem project, which has been in development for more than five years, is expected to be a game-changer for the company. The project follows Apple’s $1 billion acquisition of Intel’s modem division in 2019, a strategic move aimed at bolstering its in-house chip design capabilities. While the company has faced several challenges, including technical hurdles and management changes, it is now set to introduce its new modem by 2027, to surpass Qualcomm’s technology in the coming years.Hot on the heels of details of the supposed RTX 5070 Ti GPU come details of the next rung down in the rumoured Nvidia RTX 50 family of graphics cards. We give you the RTX 5070, the plain vanilla version and what could be a worryingly small step forward if this new "leak" is anything to go by. According to Benchlife (via Videocardz ), we're looking at 6,400 CUDA cores for the RTX 5070. That's well down on the 8,960 rumoured for the RTX 5070 Ti. Perhaps even more pertinently, it's just 9% more CUDA cores than the existing RTX 4070 and, indeed, fewer CUDA cores than the RTX 4070 Super , which rocks 7,168. Now, there is more to GPU performance than mere core count. There's clock speed, which you might expect to be up at least a little bit thanks to the transition from TSMC's N5 silicon to a revised N4 node for the Blackwell architecture that will underpin all GPUs in the RTX 50 lineup. That said, N4 is not a wholly new node compared to N5, more of an enhancement. Nvidia would have needed to make the jump to N3 for that. So, it may not be realistic to anticipate a huge jump in frequencies. That said, the new 5070 is rumoured to be rated at a board power of 250 W, which is a fair old step up on the 200 W of the 4070. So, we'll wait to see about those clock speeds and cross our fingers and toes that they're up a decent chunk. Then there's architecture. It may turn out that the Blackwell in the RTX 5070 is much more efficient than the Ada Lovelace technology in the RTX 4070 and indeed 4070 Super. So, Blackwell may do more work per clock cycle. Features like the RT cores for ray tracing and the Tensor cores for AI stuff may get a particularly big boost. In other words, the RT 4070's CUDA cores and broader per-unit performance probably won't be perfectly comparable with those of the RTX 4070 and 4070 Super. Even so, if all these rumours are correct, the gap between the RTX 5070 and 5070 Ti in terms of CUDA core count is 40%, whereas the same metric for the RTX 4070 and 4070 Ti is just 30%. Go back to the RTX 3070 versus the RTX 3070 Ti and the gap was just 4%. Now it's supposedly going to be 40%. That only adds to the impression of a distinctly weak 70-series board this time around. The biggest gaming news, reviews and hardware deals Keep up to date with the most important stories and the best deals, as picked by the PC Gamer team. If there's any good news in all this, it's that it could open the door for Intel to be competitive with the RTX 5070. As we reported earlier today, the latest rumours suggest that Intel's top Battlemage GPU for its second generation of Arc gaming graphics cards is aimed at RTX 4070 Super performance. If it achieves that, it might just be as fast or maybe even faster than the RTX 5070. Put another way, Nvidia's failure to move the game on at the '70 level could make for a much more competitive mid-range GPU market this time. AMD is likewise putting all its effort into mid-range focused GPUs for its next-gen RDNA 4 GPUs . So, there's a chance of a price war in the mid-range come the new year. OK, it's just a whisker of a chance. But a chance nonetheless. Best gaming PC : The top pre-built machines. Best gaming laptop : Great devices for mobile gaming.
Enteral Feeding Tubes Market Size: Strong Growth Ahead (2024-2032) 12-25-2024 03:11 PM CET | Health & Medicine Press release from: Cognate Insights Enteral Feeding Tubes Market Latest Market Overview The global enteral feeding tubes market is projected to reach a value of USD 2.6 billion by 2024, growing at a CAGR of 5.9% from 2024 to 2032. Enteral feeding tubes are medical devices used for delivering nutrition directly into the gastrointestinal tract of patients who are unable to eat or swallow food due to various medical conditions. These conditions include neurological disorders, gastrointestinal diseases, and cancer. The rising prevalence of chronic diseases and an aging population globally are significant factors contributing to the growing demand for enteral feeding tubes. Furthermore, advancements in tube design, materials, and ease of use are boosting adoption in both hospital and homecare settings. The Enteral Feeding Tubes Market has experienced steady growth in recent years and is expected to continue expanding at a strong pace from 2024 to 2032. This analysis offers a comprehensive overview, providing valuable insights into key trends and developments within the Enteral Feeding Tubes industry. These findings equip business leaders with the necessary knowledge to devise more effective strategies and enhance profitability. Furthermore, the report serves as a useful resource for new and emerging businesses, helping them make informed decisions as they navigate the market and seek growth opportunities. Major Players of Enteral Feeding Tubes Market are: Abbott Laboratories, USA - Revenue: USD 46.6 billion (2023) Medtronic, Ireland - Revenue: USD 30.2 billion (2023) Fresenius Kabi, Germany - Revenue: USD 7.3 billion (2023) Danone S.A., France - Revenue: USD 29.1 billion (2023) Vygon, France - Revenue: USD 1.2 billion (2023) Get Latest PDF Sample Report @ https://www.cognateinsights.com/request-sample/enteral-feeding-tubes-market Our Report covers global as well as regional markets and provides an in-depth analysis of the overall growth prospects of the market. Global market trend analysis including historical data, estimates to 2024, and compound annual growth rate (CAGR) forecast to 2032 is given based on qualitative and quantitative analysis of the market segments involving economic and non-economic factors. Furthermore, it reveals the comprehensive competitive landscape of the global market, the current and future market prospects of the industry, and the growth opportunities and drivers as well as challenges and constraints in emerging and emerging markets. Global Enteral Feeding Tubes Market Landscape and Future Pathways: North America: United States Canada Europe: Germany France U.K. Italy Russia Asia-Pacific: China Japan South Korea India Australia China Taiwan Indonesia Thailand Malaysia Latin America: Mexico Brazil Argentina Korea Colombia Middle East & Africa: Turkey Saudi Arabia UAE Korea Speak to Our Analyst for A Discussion on The Above Findings, And Ask for A Discount on The Report @ https://www.cognateinsights.com/check-discount/enteral-feeding-tubes-market Key drivers and challenges influencing the Enteral Feeding Tubes market: Regional Analysis: The report involves examining the Enteral Feeding Tubes market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets. Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Enteral Feeding Tubes market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends. Company Analysis: Report covers individual Enteral Feeding Tubes manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies. Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Enteral Feeding Tubes This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application. Technology Analysis: Report covers specific technologies relevant to Enteral Feeding Tubes. It assesses the current state, advancements, and potential future developments in Enteral Feeding Tubes areas. Reason to Buy this Report: -Analysis of the impact of technological advancements on the market and the emerging trends shaping the industry in the coming years. -Examination of the regulatory and policy changes affecting the market and the implications of these changes for market participants. -Overview of the competitive landscape in the Enteral Feeding Tubes market, including profiles of the key players, their market share, and strategies for growth. -Identification of the major challenges facing the market, such as supply chain disruptions, environmental concerns, and changing consumer preferences, and analysis of how these challenges will affect market growth. -Evaluation of the potential of new products and applications in the market, and analysis of the investment opportunities for market participants. For In-Depth Competitive Analysis - Purchase this Report now at @ https://www.cognateinsights.com/purchase-report/enteral-feeding-tubes-market Contact Us: Cognate Insights Web: www.cognateinsights.com Email: info@cognateinsights.com Phone: +91 8424946476 About Us: We are leaders in market analytics, business research, and consulting services for Fortune 500 companies, start-ups, financial & government institutions. Since we understand the criticality of data and insights, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. To be at our client's disposal whenever they need help on market research and consulting services. We also aim to be their business partners when it comes to making critical business decisions around new market entry, M&A, competitive Intelligence and strategy. This release was published on openPR.The Government of India, On Wednesday, announced a significant reshuffle of senior Indian Administrative Service (IAS) officers, with multiple key appointments made across several important departments. Rachna Shah, IAS, who was serving as the Secretary of the Ministry of Textiles, has been appointed as the new Secretary of the Department of Personnel and Training (DoPT). This department is responsible for managing India’s civil services. Shah succeeds Neelam Shammi Rao, IAS, who moves to the Ministry of Textiles, taking over from Shah in this role. Shah, a graduate in Business Economics from Delhi University, has extensive experience, having worked in several important ministries, including Science and Technology and Corporate Affairs. Also Read: Amit Shah launches 10,000 new PACS, sets target to establish 2 lakh cooperatives Arunish Chawla, IAS, who previously held the position of Secretary in the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has been appointed as Secretary of the Department of Revenue, Ministry of Finance. Chawla replaces Sanjay Malhotra, who resigned following his appointment as the Governor of the Reserve Bank of India. In addition to his new role, Chawla will also continue to hold the additional charge of Secretary at the Ministry of Culture until a permanent appointment is made. Chawla, who has served in various senior positions, including as Additional Chief Secretary for Urban Development and Housing in Bihar, brings with him a wealth of experience in administration and urban planning. Vineet Joshi, IAS, formerly serving as the Chief Secretary of Manipur, has been appointed as the new Secretary of the Department of Higher Education in the Ministry of Education. Joshi, who holds a degree in mechanical engineering from IIT Kanpur and an MBA from the Indian Institute of Foreign Trade, has a long history in civil service. He has previously worked as Additional Secretary in the Ministry of Education and also led the National Testing Agency (NTA) as its Director from 2018. Sanjay Sethi, IAS, has been appointed Secretary of the National Commission for Minorities (NCM), Ministry of Minority Affairs, in the rank and pay of Secretary to the Government of India. Sethi takes over from Neelam Shammi Rao, who has been reassigned to the Ministry of Textiles. Also Read: Allu Arjun, 'Pushpa' team give ₹2 crore aid after Hyderabad theatre stampede Sethi has had an extensive career in administrative roles, including serving as the Additional Municipal Commissioner of Projects in the Municipal Corporation of Greater Mumbai (MCGM), as well as Municipal Commissioner of Thane and Nagpur. He also held the position of CEO of the Maharashtra Industrial Development Corporation (MIDC). Amit Agrawal, IAS, who is currently the Chief Executive Officer of the Unique Identification Authority of India (UIDAI), has been appointed as the new Secretary of the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers. Agrawal succeeds Chawla, taking over the role with immediate effect. Agrawal, a graduate of IIT Kanpur, has held several senior positions, including Additional Secretary in both the Ministry of Electronics and Information Technology (MeitY) and the Ministry of Finance. His experience also includes a tenure as Finance Secretary in the state government of Chhattisgarh. Neerja Sekhar, IAS, who was serving as Special Secretary in the Ministry of Information and Broadcasting, has been appointed Director General of the National Productivity Council (NPC). The NPC, which operates under the Department for Promotion of Industry and Internal Trade, works to enhance productivity across various sectors of the Indian economy. Sekhar, an experienced bureaucrat, brings valuable expertise to her new position as she continues to contribute to India’s economic development. Also Read: Ola Electric expands network by fourfold to 4,000 stores nationwide